Clinical • Checkpoint inhibition • Next-generation sequencing • IO biomarker • Circulating tumor DNA
|
EGFR (Epidermal growth factor receptor) • HER-2 (Human epidermal growth factor receptor 2) • KRAS (KRAS proto-oncogene GTPase) • TP53 (Tumor protein P53) • FGFR2 (Fibroblast growth factor receptor 2) • STK11 (Serine/threonine kinase 11)
|
TP53 mutation • KRAS mutation • EGFR mutation • HER-2 mutation • ATM mutation • STK11 mutation • FGFR2 mutation • EGFR A763_Y764insFQEA • EGFR L747P • KRAS Q61H • EGFR E746